Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Schistosomiasis Drugs Market - 2024-2031
US$ 3,400.00
Schistosomiasis Drugs Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Schistosomiasis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analy...
October 2024
47 pages
Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029
US$ 2,970.00
The global Pharmaceutical Drying Equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. This is due to growing pre...
October 2024
227 pages
Adrenocortical Hormones API Market - 2024-2031
US$ 3,400.00
The Adrenocortical Hormones API Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
October 2024
53 pages
Lyophilized Injectable Drugs Market - 2024-2031
US$ 3,400.00
The Lyophilized Injectable Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
October 2024
54 pages
Active Pharmaceutical Ingredients: Global Markets
US$ 4,650.00
... (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing ...
October 2024
119 pages
Adrenoleukodystrophy Treatment Market - 2024-2031
US$ 3,400.00
Adrenoleukodystrophy Treatment Market reached US$ 323.36 million in 2023 and is expected to reach US$ 673.03 million by 2031, growing with a CAGR of 9.60% during the forecast period 2026-2031. The Adr...
October 2024
56 pages
Juvenile Dermatomyositis Treatment Market - 2024-2031
US$ 3,400.00
Juvenile Dermatomyositis Treatment Market reached US$ 71.15 million in 2023 and is expected to reach US$ 101.93 million by 2031, growing with a CAGR of 4.60% during the forecast period 2026-2031. The...
October 2024
60 pages
Neuromyelitis Optica (Devic's Syndrome) Market - 2024-2031
US$ 3,400.00
Neuromyelitis Optica (Devic's Syndrome) Marketis is growing with a CAGR of 4.80% during the forecast period 2026-2035. The Neuromyelitis Optica (Devic's Syndrome) Market emerges as a key focus in Data...
October 2024
65 pages
Global Heart Failure Therapeutics Market Size Study, by Treatment (Medical Devices, Medicines, Surgery), by Type (Diagnosis, Prognosis), by Stage (Stage A, Stage B, Stage C, Stage D), by End User (Clinic, Hospital, Medical Research Organization), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Heart Failure Therapeutics Market is valued at approximately USD 23.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.46% over the forecast period 202...
October 2024
285 pages
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
US$ 2,970.00
... for the growth of the clinical trial imaging market. Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the ... in the clinical trial imaging market Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for clinical trial imaging products across various regions Market Diversification: Exhaustive ...
October 2024
249 pages
Asia Pacific Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Asia Pacific Liver Disease Treatment Market reached US$ 3.84 billion in 2023 and is expected to reach US$ 5.83 billion by 2031, growing with a CAGR of 5.50% during the forecast period 2026-2031. The A...
October 2024
62 pages
Latin America Liver Disease Treatment Market - 2024-2031
US$ 2,499.00
Latin America Liver Disease Treatment Market reached US$ 1.3 billion in 2023 and is expected to reach US$ 2.02 billion by 2031, growing with a CAGR of 5.80% during the forecast period 2026-2031. The L...
October 2024
63 pages
Phenylephrine Hydrochloride Market - 2024-2031
US$ 3,400.00
The Phenylephrine Hydrochloride Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
September 2024
53 pages
Botulinum Toxin Market - 2024-2031
US$ 3,400.00
Botulinum Toxin Marketis is growing with a CAGR of 7.62% during the forecast period 2026-2035. The Botulinum Toxin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
September 2024
41 pages
Excipients in Pharmaceuticals: Global Markets to 2029
US$ 4,650.00
... future of pharmaceutical excipients market is also analyzed. Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water. Based on route of administration, the pharmaceutical excipient market is segmented ...
September 2024
105 pages
Alzheimer's Drugs – A Global Market Overview
US$ 4,500.00
Alzheimer's Drugs Market Trends and Outlook Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals...
September 2024
253 pages
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
US$ 2,970.00
The Age-Related Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029....
September 2024
336 pages
Vitamin D Therapy Market - 2024-2031
US$ 3,400.00
Vitamin D Therapy Marketis is growing with a CAGR of 12.20% during the forecast period 2026-2035. The Vitamin D Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
September 2024
43 pages
Anticoagulation Therapy Market - 2024-2031
US$ 3,400.00
The Anticoagulation Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
September 2024
49 pages
Aplastic Anemia Market - 2024-2031
US$ 3,400.00
The Aplastic Anemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
September 2024
41 pages
Alpha-mannosidosis Treatment Market - 2024-2031
US$ 3,400.00
The Alpha-mannosidosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
September 2024
54 pages
Iron Overload Syndrome Treatment Market - 2024-2031
US$ 3,400.00
The Iron Overload Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
September 2024
58 pages
Penicillin Drug Market - 2024-2031
US$ 3,400.00
Penicillin Drug Marketis is growing with a CAGR of 4.40% during the forecast period 2026-2035. The Penicillin Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
September 2024
41 pages
Primary Hyperoxaluria Treatment Market - 2024-2031
US$ 3,400.00
Primary Hyperoxaluria Treatment Market reached US$ 168.96 million in 2023 and is expected to reach US$ 365.49 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The Pr...
September 2024
57 pages
Endometriosis Drug Market - 2024-2031
US$ 3,400.00
Endometriosis Drug Marketis is growing with a CAGR of 10.40% during the forecast period 2026-2035. The Endometriosis Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
September 2024
44 pages
Cetirizine Hydrochloride Market - 2024-2031
US$ 3,400.00
Cetirizine Hydrochloride Market reached US$ 6,797.9 million in 2023 and is expected to reach US$ 8,882.5 million by 2031, growing with a CAGR of 3.40% during the forecast period 2026-2031. The Cetiriz...
September 2024
50 pages
Antibody Drugs: Technologies and Global Markets
US$ 4,650.00
... growth rate (CAGR) of 6.3% from 2017 through 2022. The global antibody drugs market for autoimmune diseases reached $37.3 billion in 2016. The market ... $37.5 billion in 2017, at a CAGR of 5.1% from 2017 through 2022. The global antibody drugs market for lymphoma reached $37.3 billion in 2016. The market should ...
September 2024
156 pages
Hazardous Drug Administration Market - 2024-2031
US$ 3,400.00
Hazardous Drug Administration Market reached US$ 459.5 million in 2023 and is expected to reach US$ 1900.9 million by 2031, growing with a CAGR of 20.20% during the forecast period 2026-2031. The Haza...
September 2024
55 pages
Osteoporosis Drugs Market - 2024-2031
US$ 3,400.00
Osteoporosis Drugs Market reached US$ 14,066.4 million in 2022 and is expected to reach US$ 19,336.6 million by 2031, growing with a CAGR of 4.10% during the forecast period 2026-2031. The Osteoporosi...
September 2024
44 pages
Drug Discovery Technologies
US$ 4,650.00
... among others. Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., ... 23 additional tables. An overview of the global markets for drug discovery technologies. Analyses of global market trends with data from 2015, 2016, and 2017, ...
September 2024
192 pages
Post Menopausal Osteoporosis Market - 2024-2031
US$ 3,400.00
Post Menopausal Osteoporosis Market reached US$ 9.9 billion in 2023 and is expected to reach US$ 15.2 billion by 2031, growing with a CAGR of 5.40% during the forecast period 2026-2031. The Post Menop...
September 2024
54 pages
G7 Spinocerebellar Ataxia Market - 2024-2031
US$ 3,400.00
G7 Spinocerebellar Ataxia Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The G7 Spinocerebellar Ataxia Market emerges as a key focus in DataM Intelligence latest in-dep...
August 2024
51 pages
Water Treatment Aerators Market - 2024-2031
US$ 3,400.00
Water Treatment Aerators Marketis is growing with a CAGR of 6.90% during the forecast period 2026-2035. The Water Treatment Aerators Market emerges as a key focus in DataM Intelligence latest in-depth...
August 2024
50 pages
Erectile Dysfunction Drugs Market - 2024-2031
US$ 3,400.00
Erectile Dysfunction Drugs Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 5.0 billion by 2031, growing with a CAGR of 4.70% during the forecast period 2026-2031. The Erectile Dysf...
August 2024
52 pages
Gastroparesis Drugs Market - 2024-2031
US$ 3,400.00
Gastroparesis Drugs Marketis is growing with a CAGR of 4.90% during the forecast period 2026-2035. The Gastroparesis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
August 2024
45 pages
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
US$ 4,650.00
... depth knowledge of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market. The contract manufacturing segment is further ... Includes: 50 data tables An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on ...
August 2024
143 pages
Human Anti-rabies Vaccine Market - 2024-2031
US$ 3,400.00
Human Anti-rabies Vaccine Marketis is growing with a CAGR of 5.70% during the forecast period 2026-2035. The Human Anti-rabies Vaccine Market emerges as a key focus in DataM Intelligence latest in-dep...
August 2024
51 pages
UAE Over the Counter (OTC) Drugs Market By Product Type (Cough, Cold and Flu, Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2019-2029F
US$ 3,500.00
UAE Over the Counter (OTC) Drugs Market was valued at USD 2.79 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.73% through 2029. Over the Cou...
August 2024
83 pages
Primary Immunodeficiency Diseases Market - 2024-2031
US$ 3,400.00
Primary Immunodeficiency Diseases Market reached US$ 7.3 billion in 2023 and is expected to reach US$ 13.0 billion by 2031, growing with a CAGR of 7.60% during the forecast period 2026-2031. The Prima...
August 2024
59 pages
Cytomegalovirus Infection Treatment Market - 2024-2031
US$ 3,400.00
Cytomegalovirus Infection Treatment Marketis is growing with a CAGR of 6.70% during the forecast period 2026-2035. The Cytomegalovirus Infection Treatment Market emerges as a key focus in DataM Intell...
August 2024
61 pages
Familial Lipoprotein Lipase Deficiency Market - 2024-2031
US$ 3,400.00
The Familial Lipoprotein Lipase Deficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
August 2024
64 pages
Pain Management Alternatives Market - 2024-2031
US$ 3,400.00
Pain Management Alternatives Market reached US$ 7.31 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 8.60% during the forecast period 2026-2031. The Pain Mana...
August 2024
54 pages
Renal Fanconi Syndrome Market - 2024-2031
US$ 3,400.00
Renal Fanconi Syndrome Market reached US$ 576.4 million in 2023 and is expected to reach US$ 767.5 million by 2031, growing with a CAGR of 3.70% during the forecast period 2026-2031. The Renal Fanconi...
August 2024
48 pages
